The potential of generative AI to accelerate antiviral development and drug discovery

In a new study, researchers from IBM, Oxford University and Diamond Light Source show that IBM's AI Model, MoLFormer, can generate antiviral molecules for multiple target virus proteins, including SARS-CoV-2, that can accelerate the drug discovery process and bolster our response to future pandemics.